Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

BACKGROUND: Glioblastoma (GBM) is the most common and lethal primary malignant glioma in adults. Dendritic cell (DC) vaccines have demonstrated promising results in GBM clinical trials. However, some patients do not respond well to DC therapy, with survival rates similar to those of conventional the...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Jan, Chia-Ing, Tsai, Wan-Chen, Harn, Horng-Jyh, Shyu, Woei-Cherng, Liu, Ming-Chao, Lu, Hsin-Man, Chiu, Shao-Chih, Cho, Der-Yang
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2018
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992384/
https://ncbi.nlm.nih.gov/pubmed/29910795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00727
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items